SEMICARBAZONE PROTEASOME INHIBITORS FOR TREATING HIV AND HEPATITIS INFECTION

摘要

The invention relates to semicarbazone proteasome inhibitors, pharmaceutical compositions comprising the same, uses of said semicarbazone proteasome inhibitors and pharmaceutical compositions comprising the same for use in the treatment of heptatis virus infections, particularly in the treatment of HCV infections and/or HIV infections.